Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 151257-01-1 | MDL No. : | MFCD03428357 |
Formula : | C11H19ClN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WWRHZLCKSVQRBG-UHFFFAOYSA-N |
M.W : | 230.73 | Pubchem ID : | 10176995 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.82 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 71.69 |
TPSA : | 41.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.43 |
Log Po/w (WLOGP) : | 2.06 |
Log Po/w (MLOGP) : | 2.18 |
Log Po/w (SILICOS-IT) : | 3.12 |
Consensus Log Po/w : | 1.96 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.6 |
Solubility : | 0.575 mg/ml ; 0.00249 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.94 |
Solubility : | 0.263 mg/ml ; 0.00114 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.39 |
Solubility : | 0.0946 mg/ml ; 0.00041 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.54 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 138402-05-8 ]
2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one
Similarity: 0.98
[ 1214028-87-1 ]
2-Methyl-1,3,7-triazaspiro[4.5]dec-2-en-4-one hydrochloride
Similarity: 0.76
[ 1253924-71-8 ]
2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one
Similarity: 0.57
[ 168899-60-3 ]
N-(tert-Butyl)decahydroisoquinoline-3-carboxamide
Similarity: 0.55
[ 136465-81-1 ]
(3S,4aS,8aS)-N-(tert-Butyl)decahydroisoquinoline-3-carboxamide
Similarity: 0.55
[ 138402-05-8 ]
2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one
Similarity: 0.98
[ 1214028-87-1 ]
2-Methyl-1,3,7-triazaspiro[4.5]dec-2-en-4-one hydrochloride
Similarity: 0.76
[ 1253924-71-8 ]
2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one
Similarity: 0.57
[ 168899-60-3 ]
N-(tert-Butyl)decahydroisoquinoline-3-carboxamide
Similarity: 0.55
[ 26081-03-8 ]
(R)-3-Aminoazepan-2-one hydrochloride
Similarity: 0.53
[ 138402-05-8 ]
2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one
Similarity: 0.98
[ 1214028-87-1 ]
2-Methyl-1,3,7-triazaspiro[4.5]dec-2-en-4-one hydrochloride
Similarity: 0.76
[ 1253924-71-8 ]
2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one
Similarity: 0.57
[ 27776-21-2 ]
1,2-Bis(2-(4,5-dihydro-1H-imidazol-2-yl)propan-2-yl)diazene dihydrochloride
Similarity: 0.51
[ 1218-35-5 ]
2-(4-(tert-Butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride
Similarity: 0.51
[ 138402-05-8 ]
2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one
Similarity: 0.98
[ 1214028-87-1 ]
2-Methyl-1,3,7-triazaspiro[4.5]dec-2-en-4-one hydrochloride
Similarity: 0.76
[ 1253924-71-8 ]
2-(4-(Trifluoromethoxy)phenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one
Similarity: 0.57
[ 699-51-4 ]
1,3-Diazaspiro[4.4]nonane-2,4-dione
Similarity: 0.51